IN THE MANAGEMENT OF TYPE 2 DIABETES*1
THE POWER TO
ACCOMPLISH
MORE
ACCOMPLISH
MORE
MULTIPLE BENEFITS.* PROVEN PROTECTION.†
How soon can we initiate SGLT2i treatment in your HF patients?
06/02/2024 | Author: Boehringer Ingelheim
Document ID: PC-MY-103363